Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis

Hugh Salamon, Ken D. Yamaguchi, Daniela M. Cirillo, Paolo Miotto, Marco Schito, James Posey, Angela M. Starks, Stefan Niemann, David Alland, Debra Hanna, Enrique Aviles, Mark D. Perkins, David L. Dolinger

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Tuberculosis remains a major global public health challenge. Although incidence is decreasing, the proportion of drug-resistant cases is increasing. Technical and operational complexities prevent Mycobacterium tuberculosis drug susceptibility phenotyping in the vast majority of new and retreatment cases. The advent of molecular technologies provides an opportunity to obtain results rapidly as compared to phenotypic culture. However, correlations between genetic mutations and resistance to multiple drugs have not been systematically evaluated. Molecular testing of M. tuberculosis sampled from a typical patient continues to provide a partial picture of drug resistance. A database of phenotypic and genotypic testing results, especially where prospectively collected, could document statistically significant associations and may reveal new, predictive molecular patterns. We examine the feasibility of integrating existing molecular and phenotypic drug susceptibility data to identify associations observed across multiple studies and demonstrate potential for well-integrated M. tuberculosis mutation data to reveal actionable findings.

Original languageEnglish
Pages (from-to)S50-S57
JournalJournal of Infectious Diseases
Volume211
DOIs
Publication statusPublished - 2015

Fingerprint

Mycobacterium tuberculosis
Databases
Mutation
Pharmaceutical Preparations
Retreatment
Multiple Drug Resistance
Drug Resistance
Tuberculosis
Public Health
Technology
Incidence

Keywords

  • Database
  • Drug resistance
  • Drug susceptibility testing
  • Genomic sequencing
  • Resistance-associated mutations
  • Tuberculosis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Medicine(all)
  • Infectious Diseases

Cite this

Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis. / Salamon, Hugh; Yamaguchi, Ken D.; Cirillo, Daniela M.; Miotto, Paolo; Schito, Marco; Posey, James; Starks, Angela M.; Niemann, Stefan; Alland, David; Hanna, Debra; Aviles, Enrique; Perkins, Mark D.; Dolinger, David L.

In: Journal of Infectious Diseases, Vol. 211, 2015, p. S50-S57.

Research output: Contribution to journalArticle

Salamon, H, Yamaguchi, KD, Cirillo, DM, Miotto, P, Schito, M, Posey, J, Starks, AM, Niemann, S, Alland, D, Hanna, D, Aviles, E, Perkins, MD & Dolinger, DL 2015, 'Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis', Journal of Infectious Diseases, vol. 211, pp. S50-S57. https://doi.org/10.1093/infdis/jiu816
Salamon, Hugh ; Yamaguchi, Ken D. ; Cirillo, Daniela M. ; Miotto, Paolo ; Schito, Marco ; Posey, James ; Starks, Angela M. ; Niemann, Stefan ; Alland, David ; Hanna, Debra ; Aviles, Enrique ; Perkins, Mark D. ; Dolinger, David L. / Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis. In: Journal of Infectious Diseases. 2015 ; Vol. 211. pp. S50-S57.
@article{6f2c2323006d49d68e9be1a2ea3e8ba8,
title = "Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis",
abstract = "Tuberculosis remains a major global public health challenge. Although incidence is decreasing, the proportion of drug-resistant cases is increasing. Technical and operational complexities prevent Mycobacterium tuberculosis drug susceptibility phenotyping in the vast majority of new and retreatment cases. The advent of molecular technologies provides an opportunity to obtain results rapidly as compared to phenotypic culture. However, correlations between genetic mutations and resistance to multiple drugs have not been systematically evaluated. Molecular testing of M. tuberculosis sampled from a typical patient continues to provide a partial picture of drug resistance. A database of phenotypic and genotypic testing results, especially where prospectively collected, could document statistically significant associations and may reveal new, predictive molecular patterns. We examine the feasibility of integrating existing molecular and phenotypic drug susceptibility data to identify associations observed across multiple studies and demonstrate potential for well-integrated M. tuberculosis mutation data to reveal actionable findings.",
keywords = "Database, Drug resistance, Drug susceptibility testing, Genomic sequencing, Resistance-associated mutations, Tuberculosis",
author = "Hugh Salamon and Yamaguchi, {Ken D.} and Cirillo, {Daniela M.} and Paolo Miotto and Marco Schito and James Posey and Starks, {Angela M.} and Stefan Niemann and David Alland and Debra Hanna and Enrique Aviles and Perkins, {Mark D.} and Dolinger, {David L.}",
year = "2015",
doi = "10.1093/infdis/jiu816",
language = "English",
volume = "211",
pages = "S50--S57",
journal = "Journal of Infectious Diseases",
issn = "0022-1899",
publisher = "Oxford University Press",

}

TY - JOUR

T1 - Integration of published information into a resistance-associated mutation database for mycobacterium tuberculosis

AU - Salamon, Hugh

AU - Yamaguchi, Ken D.

AU - Cirillo, Daniela M.

AU - Miotto, Paolo

AU - Schito, Marco

AU - Posey, James

AU - Starks, Angela M.

AU - Niemann, Stefan

AU - Alland, David

AU - Hanna, Debra

AU - Aviles, Enrique

AU - Perkins, Mark D.

AU - Dolinger, David L.

PY - 2015

Y1 - 2015

N2 - Tuberculosis remains a major global public health challenge. Although incidence is decreasing, the proportion of drug-resistant cases is increasing. Technical and operational complexities prevent Mycobacterium tuberculosis drug susceptibility phenotyping in the vast majority of new and retreatment cases. The advent of molecular technologies provides an opportunity to obtain results rapidly as compared to phenotypic culture. However, correlations between genetic mutations and resistance to multiple drugs have not been systematically evaluated. Molecular testing of M. tuberculosis sampled from a typical patient continues to provide a partial picture of drug resistance. A database of phenotypic and genotypic testing results, especially where prospectively collected, could document statistically significant associations and may reveal new, predictive molecular patterns. We examine the feasibility of integrating existing molecular and phenotypic drug susceptibility data to identify associations observed across multiple studies and demonstrate potential for well-integrated M. tuberculosis mutation data to reveal actionable findings.

AB - Tuberculosis remains a major global public health challenge. Although incidence is decreasing, the proportion of drug-resistant cases is increasing. Technical and operational complexities prevent Mycobacterium tuberculosis drug susceptibility phenotyping in the vast majority of new and retreatment cases. The advent of molecular technologies provides an opportunity to obtain results rapidly as compared to phenotypic culture. However, correlations between genetic mutations and resistance to multiple drugs have not been systematically evaluated. Molecular testing of M. tuberculosis sampled from a typical patient continues to provide a partial picture of drug resistance. A database of phenotypic and genotypic testing results, especially where prospectively collected, could document statistically significant associations and may reveal new, predictive molecular patterns. We examine the feasibility of integrating existing molecular and phenotypic drug susceptibility data to identify associations observed across multiple studies and demonstrate potential for well-integrated M. tuberculosis mutation data to reveal actionable findings.

KW - Database

KW - Drug resistance

KW - Drug susceptibility testing

KW - Genomic sequencing

KW - Resistance-associated mutations

KW - Tuberculosis

UR - http://www.scopus.com/inward/record.url?scp=84983786096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983786096&partnerID=8YFLogxK

U2 - 10.1093/infdis/jiu816

DO - 10.1093/infdis/jiu816

M3 - Article

C2 - 25765106

AN - SCOPUS:84983786096

VL - 211

SP - S50-S57

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

SN - 0022-1899

ER -